Pharmacology of imatinib (STI571)-Reference-Cited by-同舟云学术

Pharmacology of imatinib (STI571)

Published:2002-09 Issue: Volume:38 Page:S28-S36
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Buchdunger Elisabeth,O'Reilley Terence,Wood Jeanette

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference58 articles.

1. The protein tyrosine kinase family of the human genome;Robinson;Oncogene,2000

2. The hallmarks of cancer;Hanahan;Cell,2000

3. The protein tyrosine kinase family of the human genome;Al-Obeidi;Oncogene,2000

4. The molecular biology of chronic myeloid leukemia;Deininger;Blood,2000

5. Effects of a selective inhibitor of the Abl tyrosine-kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative;Buchdunger;Cancer Res,1996

Cited by 226 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular sharing and molecular-specific representations for multimodal molecular property prediction;Applied Soft Computing;2024-09

2. <i>De novo</i> design and virtual screening of potential Bcr-Abl tyrosine kinase inhibitors using deep learning and molecular modeling technologies;Doklady of the National Academy of Sciences of Belarus;2024-07-08

3. Pharmacological treatment in Idiopathic Pulmonary Fibrosis: current issues and future perspectives;Multidisciplinary Respiratory Medicine;2024-06-13

4. Design, in silico Evaluation, and Determination of Antitumor Activity of Potential Inhibitors Against Protein Kinases: Application to BCR-ABL Tyrosine Kinase;Biochemistry (Moscow);2024-06

5. Average Electron Density: A Quantitative Tool for Evaluating Non-Classical Bioisosteres of Amides;ACS Omega;2024-03-05